Koers Accretive Health, Inc. Nyse
Aandelen
US00438V1035
Gezondheidszorgvoorzieningen & -diensten
slotkoers
Andere beurzen
|
||
- USD | - |
03/07 | PE-firma New Mountain waardeert R1 RCM op bijna $6 miljard in overname-deal | RE |
03/07 | Private-equitybedrijf New Mountain doet overnamebod op R1 RCM, meldt WSJ | RE |
Omzet 2024 * | 2,61 mld. 2,42 mld. | Omzet 2025 * | 2,92 mld. 2,7 mld. | Marktkapitalisatie | 4,69 mld. 4,34 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -79 mln. -73,07 mln. | Nettowinst (verlies) 2025 * | 49 mln. 45,32 mln. | EV/omzet 2024 * | 2,54 x |
Nettoschuld 2024 * | 1,94 mld. 1,79 mld. | Nettoschuld 2025 * | 1,62 mld. 1,49 mld. | EV/omzet 2025 * | 2,16 x |
K/w-verhouding 2024 * |
-64,3
x | K/w-verhouding 2025 * |
90,1
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 34,91% |
Recentste transcriptie over Accretive Health, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Lee Rivas
CEO | Chief Executive Officer | - | 22-06-22 |
Director of Finance/CFO | - | 21-06-22 | |
John Sparby
PSD | President | 48 | 01-01-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Anthony Tersigni
BRD | Director/Board Member | 74 | 12-08-19 |
David Dill
BRD | Director/Board Member | 55 | 18-04-21 |
Joseph Flanagan
BRD | Director/Board Member | 52 | 01-04-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,64% | 85,53 mld. | |
-28,19% | 71,18 mld. | |
+0,99% | 26,41 mld. | |
+2,03% | 17,32 mld. | |
-10,31% | 17,18 mld. | |
+2,19% | 15,65 mld. | |
+78,22% | 13,71 mld. | |
-24,04% | 13,28 mld. | |
+79,75% | 13,27 mld. |